ASH: High Response to Tx After Checkpoint Blockade in NHL, HL

MONDAY, Dec. 3, 2018 -- For heavily pretreated patients with relapsed/refractory (R/R) non-Hodgkin lymphoma (NHL) or Hodgkin lymphoma (HL), response rates are high for treatment subsequent to checkpoint blockade therapy (CBT), according to two...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news